dna.hiva
Vaccineexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2003 (NCT01371175)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dna.hiva
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01371175 | Phase 2 | Apr 1, 2003 | International AIDS Vaccine Initiative, Kenya AIDS Vaccine Initiative, Medical Research Council, University of London, University of Nairobi |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 1 | 1 | 2003 |
| Kenya AIDS Vaccine Initiative | Academic/Hospital | 1 | 0 | 1 | 2003 |
| Medical Research Council | Government | 1 | 0 | 1 | 2003 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2003 |
| University of Nairobi | Academic/Hospital | 1 | 0 | 1 | 2003 |
5 organizations
Page 1 / 1